Roll-over bronchiectasis
Research payments
$767,899
Through program year 2025, $767,899 in research payments was reported against Roll-over bronchiectasis, across 52 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $50,592 | 14 |
| 2024 | Research | $717,306 | 38 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Grant Garbo San Antonio, TX Named on 13 payments
- Pamela McShane Tyler, TX Named on 6 payments
- Ryan Klein Newport Beach, CA Named on 3 payments
- Mehdi Mirsaeidi Miami, FL Named on 3 payments
- Maria Indihar Cincinnati, OH Named on 3 payments
- Peruvemba Sriram Gainesville, FL Named on 3 payments
- Doreen Addrizzo-Harris New York, NY Named on 3 payments
- Patrick Flume Charleston, SC Named on 3 payments
- Shahrukh Kureishy McKinney, TX Named on 3 payments
- Charles Andrews San Antonio, TX Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.